Research progress of PD-1/PD-L1 inhibitors in the treatment of peripheral T-cell lymphomas

Peripheral T-cell lymphomas (PTCLs) are a group of highly heterogeneous and aggressive non-Hodgkin’s lymphoma (NHL). PTCL patients have poor prognosis and high rates of relapse under the current chemotherapy-based treatment. Therefore, new drugs should be developed to improve the prognosis of PTCL....

Olles dieđut

Bibliográfalaš dieđut

Váldodahkkit:	LUO Qian, ZOU Liqun
Materiálatiipa:	Artigo
Giella:	Inglês
Almmustuhtton:	Editorial Office of China Oncology 2020-01-01
Ráidu:	Zhongguo aizheng zazhi
Fáttát:	Peripheral T-cell lymphomas Programmed death-1 Programmed death ligand-1 Immune checkpoint
Liŋkkat:	http://www.china-oncology.com/thesisDetails#10.19401/j.cnki.1007-3639.2020.12.012
Fáddágilkorat:	Lasit fáddágilkoriid Eai fáddágilkorat, Lasit vuosttaš fáddágilkora!